IHL
Click for more information
0.00% 4.1¢ incannex healthcare limited

Probability is better than average I think mate, Robert Clark...

  1. rhino78
    404 Posts.
    lightbulb Created with Sketch. 391
    clock Created with Sketch.
    14/07/24
    12:30
    Post #: 74744478
    Probability is better than average I think mate, Robert Clark has a perfect record with FDA approvals and has been heavily involved for 2 years.
    I think if phase 2 data is strong, I think they will lodge for breakthrough therapy status and with some luck, that happens by the end of the year.

    IHL Price at posting: 4.1¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 5  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

TX3 Canadian fieldwork yields multiple pegmatites for Trinex
right-arrow Created with Sketch.
IMM Immutep reports strong response rate from immunotherapies treating carcinomas
right-arrow Created with Sketch.
OBM Ora Banda sees FY26 gold output jumping to 150Koz/pa following key approval for Sand King
right-arrow Created with Sketch.
FWD Queensland's housing crisis an opportunity for ASX builder Fleetwood – and taxpayer cash a safe harbour from the storm
right-arrow Created with Sketch.
NEWS Hillcrest Energy Unveils Power Factor Correction Prototype to Meet Growing Demand
right-arrow Created with Sketch.
TX3 Canadian fieldwork yields multiple pegmatites for Trinex
right-arrow Created with Sketch.
watchlist Created with Sketch. Add IHL (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.